<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Palatino;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle18
{mso-style-type:personal;
font-family:Palatino;
color:windowtext;
font-weight:normal;
font-style:normal;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Congressionally Directed Medical Research Programs<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://cdmrp.army.mil/funding/cpmrp__;!!PhOWcWs!mYaSOEMhICuXB0oBRn2g-vmSokWioJQYZV1EklUVT9_N4eDEsokKIl4nRQqqUD7pwwUugb8JGvgtK8y0jsk$" target="_blank">Chronic Pain Management Research Program</a><br>
<b>Investigator Initiated Research Award</b><br>
Pre-application (preproposal): August 7, 2020. Application: November 6, 2020.<br>
<b>Translational Research Award</b><br>
Pre-application (preproposal): August 7, 2020. Application: November 6, 2020.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents for August 7 pre-application due date: July 27.</span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://rarediseases.org/for-clinicians-and-researchers/research-opportunities/requests-proposals/__;!!PhOWcWs!mYaSOEMhICuXB0oBRn2g-vmSokWioJQYZV1EklUVT9_N4eDEsokKIl4nRQqqUD7pwwUugb8JGvgtkUHiw7k$" target="_blank">National Organization for Research Disorders: Rare Disease
Research Grant Program</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">NORD’s Rare Disease Research Grant Program is accepting proposals for the study of the following rare diseases.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Appendix Cancer and Pseudomyxoma Peritonei (PMP) – Two 2-year grants of up to $50,000 each.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Neuroendocrine Cell Hyperplasia of Infancy (NEHI) – One grant of up to $50,000.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Initial application due August 25, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: August 12.</span></span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/pa-files/PAR-20-237.html__;!!PhOWcWs!mYaSOEMhICuXB0oBRn2g-vmSokWioJQYZV1EklUVT9_N4eDEsokKIl4nRQqqUD7pwwUugb8JGvgt4MkA3M4$" target="_blank">Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical
Trial Optional)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19
transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health
of these groups.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due August 28, 2020 and December 1, 2020.
<span style="color:red">Med-RA deadline to receive draft documents for August 28 due date: August 17.</span><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://beta.sam.gov/opp/d778e3c631274d10a3e3f334d629ab8f/view__;!!PhOWcWs!mYaSOEMhICuXB0oBRn2g-vmSokWioJQYZV1EklUVT9_N4eDEsokKIl4nRQqqUD7pwwUugb8JGvgtXMCausg$" target="_blank">DARPA: Harnessing Enzymatic Activity for Lifesaving Remedies (HEALR)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The goal of the HEALR program is to develop new medical countermeasures against bacterial pathogens and their toxins by leveraging host degradation and deactivation pathways.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due September 17, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: August 14.</span><span style="color:#1F497D">
</span><u><span style="color:red">This application requires extensive administrative effort, so the budget must be finalized no later than August 14 in order accommodate DARPA and RAMP system requirements. If you are interested in this opportunity please notify
Med-RA (research@med.fsu.edu ) and Terra Bradley (<a href="mailto:terra.bradley@med.fsu.edu"><span style="color:red">terra.bradley@med.fsu.edu</span></a>) as soon as possible.</span></u></span></b><u><span style="font-size:12.0pt;font-family:Palatino;color:red"><o:p></o:p></span></u></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-21-009.html__;!!PhOWcWs!mYaSOEMhICuXB0oBRn2g-vmSokWioJQYZV1EklUVT9_N4eDEsokKIl4nRQqqUD7pwwUugb8JGvgt0EpduM8$" target="_blank">Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01
– Clinical Trial Optional)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The purpose of this funding opportunity announcement is to support (1) research to test the efficacy or effectiveness of interventions to prevent initiation and/or escalation of ENDS (electronic
nicotine delivery system) use among adolescents; and(2 )research on the impact of tobacco control policies, including ENDS-specific policies, on adolescent ENDS use behavior. Of priority is research that is theoretically based and identifies specific risk
and protective factors to target through prevention intervention, or research on policies that can impact adolescent ENDS use. Particularly, for prevention intervention research (e.g., school, community, and clinic-based), collaboration with stakeholders and
likely program adopters is required to ensure feasibility for implementation, scalability, dissemination and sustainability. For this funding announcement, individuals as young as 12 and as old as 18 encompass the core target age range. Justification for the
specific age or age range of the target population is required, including studies that propose targeting youth outside the core age range.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due October 19, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: October 6.</span><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-042.html__;!!PhOWcWs!mYaSOEMhICuXB0oBRn2g-vmSokWioJQYZV1EklUVT9_N4eDEsokKIl4nRQqqUD7pwwUugb8JGvgtVRUyFcI$" target="_blank">3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) as a part of its
<a href="https://urldefense.com/v3/__https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative__;!!PhOWcWs!mYaSOEMhICuXB0oBRn2g-vmSokWioJQYZV1EklUVT9_N4eDEsokKIl4nRQqqUD7pwwUugb8JGvgtj0SRlto$">
Beau Biden Cancer Moonshot Initiative</a><i> </i>invites submission of applications requesting support for projects that will accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon
Panel (BRP) as Recommendation I: <i>Generation of Human Tumor Atlases</i>. The overarching goal of this FOA is to accelerate research efforts conducted and led by the Human Tumor Atlas Network (HTAN, humantumoratlas.org) via the implementation of three-dimensional
(3D) imaging technologies that will allow for a comprehensive view of the dynamic multidimensional ecosystems that define tumors in humans. Each project will lead to the multiplexed 3D characterization of at least one cancer transition investigated by the
HTAN (pre-malignant to malignant, primary to metastatic, therapy responsive to resistant). The data and analytical tools generated through this FOA will be made available for use by the research and clinical communities through the activities of the HTAN Data
Coordinating Center.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due November 9, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: October 27.</span><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.nsf.gov/pubs/2020/nsf20579/nsf20579.htm__;!!PhOWcWs!mYaSOEMhICuXB0oBRn2g-vmSokWioJQYZV1EklUVT9_N4eDEsokKIl4nRQqqUD7pwwUugb8JGvgtkRreOJ4$" target="_blank">NSF: Dynamics of Integrated Socio-Environmental Systems (DISES)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The DISES Program supports research projects that advance basic scientific understanding of integrated socio-environmental systems and the complex interactions (dynamics, processes, and
feedbacks) within and among the environmental (biological, physical and chemical) and human ("socio") (economic, social, political, or behavioral) components of such a system. The program seeks proposals that emphasize the truly integrated nature of a socio-environmental
system versus two discrete systems (a natural one and a human one) that are coupled. DISES projects must explore a connected and integrated socio-environmental system that includes explicit analysis of the processes and dynamics between the environmental and
human components of the system.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due November 16, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: November 5.<o:p></o:p></span></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:red"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">To search for additional funding opportunities, please visit </span></b><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV6980C-DCl-AxzFLHMVYQ&e=" title="https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV69"><b>CoM’s
unofficial funding opportunities blog</b></a><b>.</b><o:p></o:p></span></p>
</div>
</body>
</html>